fananserin has been researched along with mdl 100907 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, LJ; Hutson, PH; Rowley, M | 1 |
| Bentley, G; Blurton, P; Bristow, LJ; Burkamp, F; Castro, JL; Chapman, K; Cheng, SK; Clarkson, R; Cook, GP; Fletcher, SR; Hutson, PH; MacLeod, AM; Marwood, R; O'Connor, D; Patel, S; Shepheard, S; Spinks, D; Tudge, M; van Niel, MB | 1 |
| Giordanetto, F; Leach, AG; Zachariae, U | 1 |
| Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J | 1 |
| López-Giménez, JF; Mengod, G; Palacios, JM; Vilaró, MT | 2 |
2 review(s) available for fananserin and mdl 100907
| Article | Year |
|---|---|
Current and novel approaches to the drug treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists | 2001 |
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin | 2022 |
4 other study(ies) available for fananserin and mdl 100907
| Article | Year |
|---|---|
4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.
Topics: Administration, Oral; Animals; Benzamides; Biological Availability; Brain; Cation Transport Proteins; Cell Line; Cricetinae; DNA-Binding Proteins; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Ferrets; Humans; In Vitro Techniques; Male; Microsomes, Liver; Nitriles; Piperidines; Potassium Channels; Potassium Channels, Voltage-Gated; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Structure-Activity Relationship; Sulfones; Trans-Activators; Transcriptional Regulator ERG | 2002 |
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation | 2009 |
Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
Topics: Animals; Autoradiography; Binding, Competitive; Brain; Cyclic S-Oxides; Ergolines; Fluorobenzenes; Guanylyl Imidodiphosphate; In Situ Hybridization; In Vitro Techniques; Ketanserin; Male; Naphthalenes; Piperidines; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists | 1997 |
[3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
Topics: Aged; Aged, 80 and over; Animals; Binding Sites; Binding, Competitive; Brain; Cyclic S-Oxides; Ergolines; Female; Fluorobenzenes; Humans; In Situ Hybridization; Ketanserin; Macaca fascicularis; Male; Naphthalenes; Piperidines; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Tritium | 1998 |